Nuvation Bio Inc. (NUVB) Misses Q2 EPS by 3c

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $31.69 million versus the consensus estimate of $26.69 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• CoVolt Power files for proposed IPO
• Nuvectis Pharma (NVCT) files $200M mixed shelf